Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma

N L Smith1, D W Denning

  • 1The School of Translational Medicine, University of Manchester, Manchester Academic Health Science Centre and University Hospital of South Manchester, Manchester, UK. ddenning@manchester.ac.uk

Insights

Chronic pulmonary aspergillosis (CPA) is a fungal infection in non-immunocompromised individuals. Previous tuberculosis and mycobacterial infections are the most common primary underlying conditions leading to CPA.

Area of Science:

  • Medical Mycology
  • Pulmonology
  • Infectious Diseases

Background:

  • Chronic pulmonary aspergillosis (CPA) is caused by Aspergillus fumigatus in non-immunocompromised individuals.
  • Several underlying pulmonary conditions are associated with CPA, often occurring concurrently.
  • Identifying these conditions is crucial for understanding CPA development.

Purpose of the Study:

  • To analyze the distribution of underlying conditions in patients with CPA.
  • To identify the most common primary and secondary risk factors for CPA.
  • To inform clinical suspicion and diagnosis of CPA.

Main Methods:

  • Retrospective analysis of clinical notes from 126 CPA patients.
  • Extraction and categorization of all identified underlying pulmonary conditions.
  • Nomination of a primary condition when multiple conditions were present.

Main Results:

  • A total of 232 underlying conditions were identified in 126 patients.
  • Previous tuberculosis (15.3%) and non-tuberculous mycobacterial infection (14.9%) were the most frequent primary conditions.
  • Other significant conditions included allergic bronchopulmonary aspergillosis (ABPA), COPD, emphysema, pneumothorax, and prior lung cancer.

Conclusions:

  • Tuberculosis, non-tuberculous mycobacterial infection, and ABPA are predominant risk factors for CPA.
  • COPD, prior pneumothorax, and treated lung cancer are also common associated conditions.
  • CPA should be suspected in patients with lung disease exhibiting upper lobe fibrotic/cavitary changes and systemic symptoms.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation